EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study

Claus F Vogelmeier iD, Kai-Michael Beeh iD, Michael Schultze, Nils Kossack, Lena M Richter iD, Jing Claussen iD, Chris Compton iD, Stephen G Noorduyn iD, Afisi S Ismaila iD, Gema Requena iD

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s460903 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Claus F Vogelmeier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-University Marburg, German Cent…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Medication Adherence, Adrenergic beta-2 Receptor Agonists, Muscarinic Antagonists. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMedication AdherenceAdrenergic beta-2 Receptor AgonistsMuscarinic AntagonistsBronchodilator AgentsDrug CombinationsHumansMaleFemaleGermanyAgedRetrospective StudiesMiddle AgedAdministration, InhalationTreatment OutcomeQuinuclidinesTime FactorsDatabases, FactualChlorobenzenesAdministrative Claims, HealthcareDrug Therapy, CombinationBenzyl AlcoholsNebulizers and VaporizersGlycopyrrolateLung

Stichwörter der Autor:innen

comparativemultiple- or single-inhaler triple therapynew-userproportion of days coveredreal-world analysistreatment discontinuation

Substanzen

Adrenergic beta-2 Receptor AgonistsMuscarinic AntagonistsBronchodilator AgentsDrug CombinationsGSK573719QuinuclidinesChlorobenzenesBenzyl AlcoholsGlycopyrrolate

Autor:innen und Institutionen

  • Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.
  • Insaf Respiratory Research Institute, Wiesbaden, Germany.
  • ZEG - Berlin Center for Epidemiology and Health Research GmbH, Berlin, Germany.
  • WIG2 GmbH (Wissenschaftliches Institut für Gesundheitsökonomie und Gesundheitssystemforschung) - Scientific Institute for Health Economics and Health System Research, Leipzig, Germany.
  • Global Medical Affairs, GSK, Munich, Germany.
  • Global Medical, GSK, Brentford, UK.

ORCID-Profile: Claus F Vogelmeier, Kai-Michael Beeh, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena

Förderung

  • GSK

Zitieren

APA

Vogelmeier, C. F., Beeh, K. M., Schultze, M., Kossack, N., Richter, L. M., Claussen, J., Compton, C., Noorduyn, S. G., Ismaila, A. S., & Requena, G. (2024). Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s460903

Vancouver

Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, et al. Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s460903

BibTeX
@article{Vogelmeier2024,
  author = {Vogelmeier, Claus F and Beeh, Kai-Michael and Schultze, Michael and Kossack, Nils and Richter, Lena M and Claussen, Jing and Compton, Chris and Noorduyn, Stephen G and Ismaila, Afisi S and Requena, Gema},
  title = {Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s460903}
}
Kostenlos starten →